Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Lille’s Macopharma uses cell therapy to fight diabetes

07 Apr 2015 | Health Nutrition, A region on the move

Lille-based Macopharma, a major specialist player in pharmaceuticals, has developed an automated culturing system to optimize preservation of pancreatic islets—cells that play a key role in treating diabetes.

Prisma—a pioneer in diabetes therapy

Macopharma’s revolutionary Prisma (Pancreatic Islet System Automate unit) breaks new ground in biotherapy.  The product of four years of R&D, this new machine automatically preserves pancreatic islets, the insulin-secreting cells that are used to treat patients with type 1 diabetes.

Patented technology, bold commercial roll-out

Prisma uses three patented systems: a disposable medical device, a cell chamber that preserves the islets, and a specially optimized cell culture medium. “We’ve already deployed Prisma at three major cell therapy centers,” says Bruno Delorme, head of Biotherapy R&D at Macopharma. “These are Lille’s University Hospital Center (CHRU), our co-developer, plus units in Switzerland and in Sweden.

 

 

Source: Les Echos, Nicole Buyse

 

 

Back to news

News

Coca-Cola is investing €19M in Dunkirk

Coca-Cola European Partners will invest €19M in its largest plant in France, located in Socx (near Dunkirk). A new ultra-modern glass bottle production line is scheduled to open in 2019.

Rafaut opens a next-generation factory in Valenciennes

The aeronautics sector has been constantly growing in Hauts-de-France. And for good reason, after Safran’s new location in Rosult and SKF’s development in Rouvignies, Rafaut is investing €20M to create a new...

All news